FindTrial
Sign In

Evaluation of the bioequivalence of two intravaginal gel preparations containing 90 mg progesterone

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-520498-38-00
Enrollment
48
Registered
2026-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No therapeutic indication in the current trial with healthy volunteers.

Interventions

None listed

Sponsors

CCDRD Cooperative Clinical Drug Research and Development AG, Ioulia And Irene Tseti Pharmaceutical Laboratories S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Sep 11, 2026